美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA215802"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0527-4661-37 0527-4661 HUMAN PRESCRIPTION DRUG Lisdexamfetamine Dimesylate Lisdexamfetamine Dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA215802 Lannett Company, Inc. LISDEXAMFETAMINE DIMESYLATE 10 mg/1 100 CAPSULE in 1 BOTTLE (0527-4661-37)
0527-4662-37 0527-4662 HUMAN PRESCRIPTION DRUG Lisdexamfetamine Dimesylate Lisdexamfetamine Dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA215802 Lannett Company, Inc. LISDEXAMFETAMINE DIMESYLATE 20 mg/1 100 CAPSULE in 1 BOTTLE (0527-4662-37)
0527-4663-37 0527-4663 HUMAN PRESCRIPTION DRUG Lisdexamfetamine Dimesylate Lisdexamfetamine Dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA215802 Lannett Company, Inc. LISDEXAMFETAMINE DIMESYLATE 30 mg/1 100 CAPSULE in 1 BOTTLE (0527-4663-37)
0527-4664-37 0527-4664 HUMAN PRESCRIPTION DRUG Lisdexamfetamine Dimesylate Lisdexamfetamine Dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA215802 Lannett Company, Inc. LISDEXAMFETAMINE DIMESYLATE 40 mg/1 100 CAPSULE in 1 BOTTLE (0527-4664-37)
0527-4665-37 0527-4665 HUMAN PRESCRIPTION DRUG Lisdexamfetamine Dimesylate Lisdexamfetamine Dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA215802 Lannett Company, Inc. LISDEXAMFETAMINE DIMESYLATE 50 mg/1 100 CAPSULE in 1 BOTTLE (0527-4665-37)
0527-4666-37 0527-4666 HUMAN PRESCRIPTION DRUG Lisdexamfetamine Dimesylate Lisdexamfetamine Dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA215802 Lannett Company, Inc. LISDEXAMFETAMINE DIMESYLATE 60 mg/1 100 CAPSULE in 1 BOTTLE (0527-4666-37)
0527-4667-37 0527-4667 HUMAN PRESCRIPTION DRUG Lisdexamfetamine Dimesylate Lisdexamfetamine Dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA215802 Lannett Company, Inc. LISDEXAMFETAMINE DIMESYLATE 70 mg/1 100 CAPSULE in 1 BOTTLE (0527-4667-37)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase